- Products
- Our Products
- Services
- All Custom Services
- Custom Protein Services
- Custom Antibody Services
- Assay Custom Services
- Luminex Custom Services
- Custom Services for Cell & Gene Therapies
- Custom Cell Culture Media Services
- Bioactivity Testing Services
- Ubiquitin/Proteasome Custom Services
- Chemistry Services
- Bulk/Custom Formulation
- Custom cDNA Cloning
Expedite Your Research
Expedite Your Research- CometAssay® Custom Services
- Pathways
- Resources
- Research Areas
- Protocols/Troubleshooting Guides/Videos
- Technical Information
- Articles
- Help & FAQs
- Literature
- Request Literature
- Calculators
- Posters
- Blog
- Promotions
- Travel Grants
Posters, Brochures, Whitepapers & Reference Guides
Request Literature- Cell Markers
- New Lab Program
- R&D Systems Quality
- Quality Philosophy
- People
- Place
- Performance
- Product Development
- Customer Satisfaction
- The R&D Systems Quality Advantage
- Documents, Certifications, & FAQs
Experts in Reagent Quality
R&D Systems Quality
- About Us
- Careers
- Bio-Techne Brands
- Investor Relations
Our People are Our Greatest Asset
Join Us
- Contact Us
R&D Systems offers biosimilar antibodies for research use only. Our biosimilar antibodies are designed to be used as controls with our anti-idiotype antibodies. We offer many biosimilar antibodies that are conjugated or unconjugated to fit your needs. Biosimilar antibodies are expressed recombinantly using the same sequence as the original therapeutic antibody.
Bridging Assay
The biosimilar antibody is used in a bridging assay with anti-idiotype antibodies. In figure 1b, Anti-Rituximab (Anti-Idiotype) Antibody is coated to a plate to capture Rituximab Biosimilar. Then, biotinylated Anti-Rituximab (Anti-Idiotype) Antibody is used to detect Rituximab Biosimilar followed by streptavidin-HRP.
|
Fig. 1a Diagram of Bridging Assay  |
Fig. 1b Rituximab Biosimilar used in a Bridging Assay  |
R&D Systems also offers many anti-idiotype antibodies to be used with our biosimilar antibodies.